903 related articles for article (PubMed ID: 28232276)
1. Cannabidiol: State of the art and new challenges for therapeutic applications.
Pisanti S; Malfitano AM; Ciaglia E; Lamberti A; Ranieri R; Cuomo G; Abate M; Faggiana G; Proto MC; Fiore D; Laezza C; Bifulco M
Pharmacol Ther; 2017 Jul; 175():133-150. PubMed ID: 28232276
[TBL] [Abstract][Full Text] [Related]
2. Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.
Bielawiec P; Harasim-Symbor E; Chabowski A
Front Endocrinol (Lausanne); 2020; 11():114. PubMed ID: 32194509
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of the antipsychotic properties of cannabidiol in humans.
Iseger TA; Bossong MG
Schizophr Res; 2015 Mar; 162(1-3):153-61. PubMed ID: 25667194
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
[TBL] [Abstract][Full Text] [Related]
5.
Canseco-Alba A; Rodríguez-Manzo G
Rev Invest Clin; 2023; 75(3):105-128. PubMed ID: 37441766
[TBL] [Abstract][Full Text] [Related]
6. Neurological Aspects of Medical Use of Cannabidiol.
Mannucci C; Navarra M; Calapai F; Spagnolo EV; Busardò FP; Cas RD; Ippolito FM; Calapai G
CNS Neurol Disord Drug Targets; 2017; 16(5):541-553. PubMed ID: 28412918
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.
Yousaf M; Chang D; Liu Y; Liu T; Zhou X
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956911
[TBL] [Abstract][Full Text] [Related]
8. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Fride E; Ponde D; Breuer A; Hanus L
Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
Newton M; Newton DW
J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
[No Abstract] [Full Text] [Related]
10. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
[TBL] [Abstract][Full Text] [Related]
11. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
Fasinu PS; Phillips S; ElSohly MA; Walker LA
Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
[TBL] [Abstract][Full Text] [Related]
12. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
Reddy DS; Golub VM
J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol as potential anticancer drug.
Massi P; Solinas M; Cinquina V; Parolaro D
Br J Clin Pharmacol; 2013 Feb; 75(2):303-12. PubMed ID: 22506672
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment.
Premoli M; Aria F; Bonini SA; Maccarinelli G; Gianoncelli A; Pina SD; Tambaro S; Memo M; Mastinu A
Life Sci; 2019 May; 224():120-127. PubMed ID: 30910646
[TBL] [Abstract][Full Text] [Related]
15. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
[No Abstract] [Full Text] [Related]
17. Considerations and Implications of Cannabidiol Use During Pregnancy.
Sarrafpour S; Urits I; Powell J; Nguyen D; Callan J; Orhurhu V; Simopoulos T; Viswanath O; Kaye AD; Kaye RJ; Cornett EM; Yazdi C
Curr Pain Headache Rep; 2020 Jun; 24(7):38. PubMed ID: 32524214
[TBL] [Abstract][Full Text] [Related]
18. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
Deiana S
Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
[TBL] [Abstract][Full Text] [Related]
19. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
Peng J; Fan M; An C; Ni F; Huang W; Luo J
Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
[TBL] [Abstract][Full Text] [Related]
20. Phytocannabinoids as novel therapeutic agents in CNS disorders.
Hill AJ; Williams CM; Whalley BJ; Stephens GJ
Pharmacol Ther; 2012 Jan; 133(1):79-97. PubMed ID: 21924288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
